Skip to main content
. Author manuscript; available in PMC: 2010 Mar 3.
Published in final edited form as: J Neuropathol Exp Neurol. 2008 Jul;67(7):677–686. doi: 10.1097/NEN.0b013e31817e5c5e

Table 3.

Table 3A. Subplate Neuron Immunostaining
Marker Control PVL
HNE 7/22 (32%) 10/11 (91%)
MDA 11/22 (50%) 9/11 (82%)
NT 2/21 (10%) 5/10 (50%)
Table 3B. Cajal-Retzius Cell Immunostaining
Marker Control PVL
HNE 8/19 (42%) 9/10 (90%)
MDA 8/21 (38%) 9/11 (82%)
NT 0/21 (0%) 3/9 (33%)

Numbers in each cell indicate the fraction of cases with positive immunostaining for the marker over the total number of cases with available staining (percentage).